Results 41 to 50 of about 152,575 (181)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
GHMJ (Global Health Management Journal)As the GHMJ (Global Health Management Journal) continues to advance integrated solutions for global health challenges, this edition highlights cutting-edge research and innovations spanning from molecular science to health systems strengthening.
GHMJ (Global Health Management Journal)
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and ...
Kenichi Kono +7 more
wiley +1 more source
GHMJ (Global Health Management Journal)The Editorial Board would like to extend its sincere appreciation to the reviewers who contributed their time and scholarly expertise to the issue of the Global Health Management Journal (Vol. 9, No. 1, 2026).
GHMJ (Global Health Management Journal)
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
GHMJ (Global Health Management Journal)GHMJ (Global Health Management Journal) is proud to announce the successful publication of 18 high-quality articles across the first, second, and third editions of its seventh year. Each published article represents the culmination of a rigorous process,
GHMJ (Global Health Management Journal)
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa +7 more
wiley +1 more source
Reviewer Acknowledgements: GHMJ (Global Health Management Journal), Volume 8, Number 1, 2025
GHMJ (Global Health Management Journal)As GHMJ (Global Health Management Journal) celebrates its 8th anniversary, we take this opportunity to express our deepest gratitude to the dedicated reviewers whose expertise and insights have significantly contributed to the quality and integrity of ...
GHMJ (Global Health Management Journal)
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
GHMJ (Global Health Management Journal)The Editorial Board would like to express its sincere gratitude to the reviewers who contributed their time, insight, and scholarly judgment to the issue of the Global Health Management Journal (Vol. 8, No. 3, 2025).
GHMJ (Global Health Management Journal)
doaj +1 more source